Evaluation of Safety and Efficacy of Lumason/SonoVue in Subjects Undergoing Pharmacologic Stress BR1-142

计划入组 174 人 · 首次发布于 2015 年 9 月 17 日

Evaluation of Safety and Efficacy of Lumason/SonoVue in Subjects Undergoing Pharmacologic Stress BR1-141

计划入组 175 人 · 首次发布于 2015 年 8 月 13 日

SonoVue Guided Prostate Biopsy

计划入组 282 人 · 首次发布于 2009 年 6 月 1 日

1,2-Distearoyllecithin(Lumason)

C₄₄H₈₈NO₈P

Sulfur hexafluoride(Lumason, Sonovue, SonoVue)

F₆S

Perfluorobutane

C₄F₁₀ · Rx

Sonivie, Inc.

United States

Sonova AG

Switzerland

Soovu Labs, Inc.

United States

Bracco's VueJect Receives FDA 510(k) Clearance and Health Canada Authorization as First Dedicated Ultrasound Contrast Delivery System for Cardiology Imaging

Nationwide Study Confirms Safety of LUMASON® Ultrasound Enhancing Agent in Echocardiography

Bracco Imaging Receives NMPA Approval for SonoVue in Female Infertility Assessment in China